Lisa Baderoon has spent over 20 years working within the City of London and has been involved with a diverse portfolio of clients from a variety of sectors but with a leaning towards emerging, high growth businesses advising both private and public companies on their media and investor relations strategies. During this time she has been involved in a multitude of client transactions spanning private fund raisings, Initial Public Offerings (IPO’s) and mergers and acquisitions both in the UK and internationally. Until December 2011 she was a Partner at Buchanan Communications, one of the leading City financial public relations agencies, where she was instrumental in establishing its successful healthcare franchise. Her client responsibilities included developing impactful IR strategies in addition to excellence in message development and managing relationships with media, the investment community and sell side analysts in Europe. She also has significant issue and crisis management experience from both an investor and media perspective. Over the last six years she has been advising ImmuPharma as a client on its media and investor relations strategy and in February 2012 was appointed Head of Investor Relations at the Company. Lisa has also recently founded Just B Communications, a consultancy which specialises in helping businesses develop effective communications and through her network of blue-chip London City contacts providing access to a number of sources of corporate and investor development opportunities. Lisa Baderoon has spent over 20 years working within the City of London and has been involved with a diverse portfolio of clients from a variety of sectors but with a leaning towards emerging, high growth businesses advising both private and public companies on their media and investor relations strategies. During this time she has been involved in a multitude of client transactions spanning private fund raisings, Initial Public Offerings (IPO’s) and mergers and acquisitions both in the UK and internationally. Until December 2011 she was a Partner at Buchanan Communications, one of the leading City financial public relations agencies, where she was instrumental in establishing its successful healthcare franchise. Her client responsibilities included developing impactful IR strategies in addition to excellence in message development and managing relationships with media, the investment community and sell side analysts in Europe. She also has significant issue and crisis management experience from both an investor and media perspective. Over the last six years she has been advising ImmuPharma as a client on its media and investor relations strategy and in February 2012 was appointed Head of Investor Relations at the Company. Lisa has also recently founded Just B Communications, a consultancy which specialises in helping businesses develop effective communications and through her network of blue-chip London City contacts providing access to a number of sources of corporate and investor development opportunities.

Radiology, Oncology, Cancer research